Cargando…
The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review
BACKGROUND: Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened life expectancy compared to the general population. Cardiovascular disease, due to cardiometabolic risk and metabolic syndrome, accounts for most of this excess mortality. A scoping search revealed that...
Autores principales: | Sud, Dolly, Laughton, Eileen, McAskill, Robyn, Bradley, Eleanor, Maidment, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015120/ https://www.ncbi.nlm.nih.gov/pubmed/33789745 http://dx.doi.org/10.1186/s13643-021-01586-9 |
Ejemplares similares
-
The experiences of the caring dyad: (Un)articulated realities of living with cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness
por: Sud, Dolly, et al.
Publicado: (2021) -
Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness
por: Younas, Mediha, et al.
Publicado: (2016) -
Recruiting people with severe mental illness through community pharmacies: real-world experiences from a UK study
por: Macfarlane, Hannah, et al.
Publicado: (2020) -
Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness
por: Lang, Donna J., et al.
Publicado: (2013) -
Medication optimisation in severe mental illness (MEDIATE): protocol for a realist review
por: Maidment, Ian, et al.
Publicado: (2022)